Watch as Michael R. Clark, MD, MPH, MBA, associate professor and director of the Chronic Pain Treatment Programs and department of Psychiatry and Behavioral Sciences at Johns Hopkins Medical Institutions, talks about the consequences of pain going undiagnosed or untreated—particularly in terms of the impact on quality of life, and the importance of engaging patients early.
Even short-term treatment with nonsteroidal anti-inflammatory drugs is associated with significant increases in bleeding and cardiovascular event risk in patients receiving antithrombotic therapy after a heart attack.
Most people hear “hospice” and think “cancer,” but many end-stage chronic obstructive pulmonary disease patients also receive hospice care when their caregivers can no longer provide the medical attention they need.
Narcotics are not recommended for managing chronic pain in children with inflammatory bowel disease, due to gastrointestinal side effects and potential dependence. Nevertheless, researchers have uncovered that long-term narcotic use is more than twice as prevalent in pediatric IBD patients compared with the general population.